Advertisement
Screener

Zoetis Inc. (ZTS) Form SCHEDULE 13G: Beneficial ownership report (passive)

3.0 / 5 stars · 73/120 Roast Me

Add as a preferred source on Google

Zoetis Inc. Form SCHEDULE 13G: Beneficial ownership report (passive)

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-07-30: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X02/primary_doc.xml.
  • 2026-04-30: Form SCHEDULE 13G; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X02/primary_doc.xml.
  • 2026-04-29: Form SCHEDULE 13G; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X02/primary_doc.xml.
  • 2026-03-27: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X02/primary_doc.xml.
FiledFormPeriod of reportDescriptionDocument
2026-07-30SCHEDULE 13G/ABeneficial ownership report (passive)xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-30SCHEDULE 13GBeneficial ownership report (passive)xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-29SCHEDULE 13GBeneficial ownership report (passive)xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-27SCHEDULE 13G/ABeneficial ownership report (passive)xslSCHEDULE_13G_X02/primary_doc.xml
2026-01-07SCHEDULE 13G/ABeneficial ownership report (passive)xslSCHEDULE_13G_X01/primary_doc.xml

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
Advertisement